-->

Perceptions, Barriers, and Opportunities to Strengthen Tuberculosis Prevention and Control in Nigeria: A Qualitative Study of Policymakers and Program Managers

Download Article

DOI: 10.21522/TIJPH.2013.14.03.Art009

Authors : Emperor Ubochioma, Aniwada Elias Chikee, George Ikpe, Joseph Kuye

Abstract:

Policymakers and program managers play a critical role in shaping tuberculosis (TB) control strategies, yet their perspectives on implementation barriers remain underexplored. This qualitative study examined perceptions of TB control, preventive activities, and implementation challenges in Nigeria. Nine key informants from national and subnational TB programs and partner organizations were purposively selected. Data were collected through in-depth interviews and analyzed thematically in NVivo 12. Participants reported progress in TB control, including the expansion of community-based services, improved access to diagnostics, the scale-up of tuberculosis preventive therapy (TPT), and strengthened monitoring systems. However, these gains are constrained by persistent system-level and contextual barriers. Stigma, low awareness, and financial constraints limit uptake of preventive services, while workforce shortages, staff attrition, supply chain inefficiencies, and reliance on paper-based reporting undermine program effectiveness. Respondents emphasized the need for service integration, increased domestic financing, and accelerated digitalization. TB control efforts in Nigeria are advancing but remain constrained by structural limitations. Addressing these gaps will require coordinated strategies to strengthen health systems, expand access, and improve program efficiency.

References:

[1].   World Health Organization. Global Tuberculosis Report 2024. Geneva: World Health Organization; 2024. https://www.who.int/publications/i/item/9789240083851

[2].   Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, et al. Tuberculosis. Nat Rev Dis Primers. 2016;2(1). https://doi.org/10.1038/nrdp.2016.76

[3].   World Health Organization. Recommended TPT regimens. WHO TB Knowledge Sharing Platform; 2024. https://tbksp.who.int/en/node/1271

[4].   World Health Organization. WHO consolidated guidelines on tuberculosis. Module 1: prevention – tuberculosis preventive treatment. Geneva: World Health Organization; 2020. https://iris.who.int/server/api/core/bitstreams/f4eae88f-c458-4c74-80d6-19ee96d09765/content

[5].   World Health Organization. Global Tuberculosis Report 2023. Geneva: World Health Organization; 2023. https://iris.who.int/server/api/core/bitstreams/cc23b85f-72c0-4177-8137-cb1161da1025/content

[6].   Storla DG, Yimer S, Bjune GA. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health. 2008;8(15). https://doi.org/10.1186/1471-2458-8-15

[7].   Creswell J, Sahu S, Blok L, Bakker MI, Stevens R, Ditiu L. A multi-site evaluation of innovative approaches to increase tuberculosis case notification: Summary results. PLoS One. 2014;9(4). https://doi.org/10.1371/journal.pone.0094465

[8].   Khan WM, Smith H, Qadeer E, Hassounah S. Knowledge and perceptions of national and provincial tuberculosis control programme managers in Pakistan about the WHO Stop TB strategy: A qualitative study. JRSM Open. 2016;8(1). https://doi.org/10.1177/2054270416675084

[9].   Hanson CL, Osberg M, Brown J, Durham G, Chin DP. Conducting patient-pathway analysis to inform programming of tuberculosis services: Methods. J Infect Dis. 2017;216(7). https://doi.org/10.1093/infdis/jix387

[10].  Giridharan P, Suseela RP, Zangpo T, Joshi RB, Cader M, Isbaniah F, et al. Tuberculosis preventive treatment in eight SEAR countries – Current practices, implementation challenges and operations research priorities. Public Health Pract. 2024;8(2024). https://doi.org/10.1016/j.puhip.2024.100518

[11].  Ihesie A, Chukwuogo O, Eneogu R, Daniel OK, Agbaje A, Odume B, et al. Acceptance and completion rates of 3-month isoniazid-rifampicin (3HR) tuberculosis preventive treatment among contacts of bacteriologically confirmed TB patients —Patients’ and healthcare workers’ perspectives. Trop Med Infect Dis. 2024;9(12). https://doi.org/10.3390/tropicalmed9120301

[12].  Craig GM, Daftary A, Engel N, O’Driscoll S, Ioannaki A. Tuberculosis stigma as a social determinant of health: A systematic mapping review of research in low incidence countries. Int J Infect Dis. 2017;56(3). https://doi.org/10.1016/j.ijid.2016.10.011

[13].  Courtwright A, Turner AN. Tuberculosis and stigmatization: Pathways and interventions. Public Health Rep. 2010;125(4). https://doi.org/10.1177/00333549101250S407

[14].  Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, et al. WHO’s new End TB Strategy. Lancet. 2015;385(9979). https://doi.org/10.1016/S0140-6736(15)60570-0

[15].  Odone A, Roberts B, Dara M, Van Den Boom M, Kluge H, McKee M. People- and patient-centred care for tuberculosis: Models of care for tuberculosis. Int J Tuberc Lung Dis. 2018;22(2). https://doi.org/10.5588/ijtld.17.0608

[16].  Naidoo S, Seevnarain K, Nordstrom DL. Tuberculosis infection control in primary health clinics in eThekwini, KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis. 2012;16(12). https://doi.org/10.5588/ijtld.12.0041

[17].  Tiruneh MG, Fenta ET, Anagaw TF, Bogale EK, Delie AM. Tuberculosis infection control practice and associated factors among healthcare workers in Ethiopia: Systematic review and meta-analysis. PLoS One. 2023;18(12). https://doi.org/10.1371/journal.pone.0295555

[18].  Marme G, Rutherford S, Harris N. What tuberculosis infection control measures are effective in resource-constrained primary healthcare facilities? A systematic review of the literature. Rural Remote Health. 2023;23(1). https://doi.org/10.22605/RRH7175

[19].  Tanimura T, Jaramillo E, Weil D, Raviglione M, Lönnroth K. Financial burden for tuberculosis patients in low- and middle-income countries: A systematic review. Eur Respir J. 2014;43(6). https://doi.org/10.1183/09031936.00193413

[20].  Kuye J, Sindani IS, Shube MA, Salah MJ, Hilowle AA, Rusagara V, et al. Households of tuberculosis (TB) patients face high TB-related costs in Somalia. BMC Glob Public Health. 2025;3(1). https://doi.org/10.1186/S44263-025-00175-5

[21].  Subbaraman R, Nathavitharana RR, Mayer KH, Satyanarayana S, Chadha VK, Arinaminpathy N, et al. Constructing care cascades for active tuberculosis: A strategy for program monitoring and identifying gaps in quality of care. PLoS Med. 2019;16(2). https://doi.org/10.1371/journal.pmed.1002754